2012
DOI: 10.1159/000337418
|View full text |Cite
|
Sign up to set email alerts
|

Alterations of Deadenylase Expression in Acute Leukemias: Evidence for Poly(A)-Specific Ribonuclease as a Potential Biomarker

Abstract: Background/Aims: The degradation of mRNA is a key process in the control of gene expression correlated to anomalous cell proliferation. The rate-limiting step of mRNA degradation is the removal of the poly(A) tail by deadenylases. However, studies on deadenylase expression in cancer are limited. Herein, we analyzed the expression of several deadenylases from acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML). Methods: Clinical samples from patients diagnosed with ALL and AML were the source of… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
48
0
2

Year Published

2014
2014
2020
2020

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 42 publications
(50 citation statements)
references
References 84 publications
0
48
0
2
Order By: Relevance
“…However, the knowledge remains very limited for the regulators of mRNA decay and the pairwise relationships for elements-factors-deadenylases [2]. PARN has been proposed to be a potential target of cancer treatment [7] and is highly expressed in acute leukemias [34] and gastric cancers (this research). Further research is needed to fully decipher the physiological/pathological functions and the key mRNA targets of PARN as well as the other deadenylases.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…However, the knowledge remains very limited for the regulators of mRNA decay and the pairwise relationships for elements-factors-deadenylases [2]. PARN has been proposed to be a potential target of cancer treatment [7] and is highly expressed in acute leukemias [34] and gastric cancers (this research). Further research is needed to fully decipher the physiological/pathological functions and the key mRNA targets of PARN as well as the other deadenylases.…”
Section: Discussionmentioning
confidence: 99%
“…Knockdown of PARN increases the migration rate of mouse myoblasts [33]. Moreover, PARN has been found to have a high expression level in acute leukemias [34]. These observations suggest that PARN plays a role in cellular processes involving the action of p21.…”
Section: Introductionmentioning
confidence: 88%
See 1 more Smart Citation
“…[94][95][96][97] PARN is phosphorylated and its levels are increased in acute lymphocytic leukemia (ALL), and acute myeloid leukemia (AML). 98 Similarly, PARN levels are altered in lung cancers, 95 suggesting a clinical significance of PARN in cancer apart from development. In G0, PARN cap binding and deadenylase activity increases, which causes deadenylation of mRNAs.…”
Section: Parn Is Essential For Fxr1a-micrornp Mediated Translation Asmentioning
confidence: 99%
“…59,121,[129][130][131][132][133] Consistently, components of the FXR1a-microRNP are implicated in cancer progression: FXR1 is known to promote tumor invasion and progression, 30 while its interacting partners, PARN and p97, are increased in activity or levels in many cancers. 98,134 Targeting components of the FXR1a-microRNP mechanism or associated microRNAs may help block translation of critical genes required for maintaining dormant cancer cells, and might be a promising approach against cancer recurrence.…”
Section: Fxr1a-micrornp Mediates Translation Of Important Genesmentioning
confidence: 99%